LOUISVILLE, Ky. — Dupilumab improved symptoms among patients with chronic rhinosinusitis with nasal polyps regardless of baseline severity of smell loss, according to study results.
CRSwNP is associated with a high symptom burden and poor health-related quality of life, according to Zachary M. Soler, MD, MSc, professor in the department of otolaryngology, head and neck surgery at Medical University of South Carolina, and colleagues. Smell loss correlates with disease severity and is one of its cardinal symptoms, with a significant detrimental impact on quality of life, the researchers